Although these findings should be interpreted with caution due to the low number of patients analyzed, they are in line with the acknowledged role of the Fas/FasL pathway in driving tumor immune evasion, metastasis, and chemoresistance [19,32,33,34]. The gene discussed is FAS; the disease is neoplasm.